The VIDA After COVID Study
Not Applicable
Withdrawn
- Conditions
- Covid19
- Registration Number
- NCT04945590
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to objectively identify and address social determinants of health (SDOH) priorities and barriers in Latino patients who survived or are vulnerable to COVID-19, and to understand the consequences of COVID-19 survivorship in local Latino communities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Study population will be identified via community partnerships and peer referrals.
- Participants include Latino families in Southern Minnesota (Dover, Olmsted and Mower county, Minnesota) who survived COVID-19 after requiring ICU or hospital admission, and their families and/or their care partners, or Latino patients who are vulnerable to COVID-19, that have provided research authorization o identified via electronic health registries (following Institutional Review Board approved guidelines).
Exclusion Criteria
- Families that do not identify as Latino.
- Those living outside Dover, Olmsted and Mower County, Minnesota.
- Those that do not provide written consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Social Determinants of Health (SDOH) Assessment Completed Through study completion, approximately 3 months Number of families in whom SDOH were assessed at baseline and follow-up interviews.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SDOH impact on post-COVID-19 outcomes in Latino populations?
How does virtual intervention compare to standard care in addressing SDOH for post-COVID-19 Latino patients?
What biomarkers correlate with vulnerability to post-COVID-19 SDOH challenges in Latino communities?
What adverse events are associated with virtual behavioral interventions targeting SDOH in post-COVID-19 care?
Are there combination approaches involving virtual interventions and pharmacologic agents for post-COVID-19 SDOH management?